Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin with or without dexamethasone for chronic subdural hematoma
ChiCTR-IPR-14005573Phase 4Recruiting
- Sponsor
- Tianjin Medical University General Hospital
- Start
- May 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of atorvastatin and dexamethasone in Chronic subdural haematoma (CSDH) (2 arms), sponsored by Tianjin Medical University General Hospital. Primary endpoint: Change in hematoma volume on CT before and after treatment. Started May 2014; status: recruiting.
02
Drugs
atorvastatindexamethasone
03
Conditions
Chronic subdural haematoma (CSDH)
Beyond the preview
Go deeper on ChiCTR-IPR-14005573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-14005573.